Evidence map›Paper›PMID 36698964›Full record

ArticleComputational and structural biotechnology journal2023

Dual guide RNA-mediated concurrent C&G-to-T&A and A&T-to-G&C conversions using CRISPR base editors.

Yuting Zhao, Min Li, Jie Liu, Xiaowen Xue, Jingli Zhong, Jianxiang Lin, Bo Ye, Jun Chen, Yunbo Qiao

Open access · goldAbstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. CRISPR/Cas9 as a Mutagenic Factor.International journal of molecular sciences · 2024
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Yuting ZhaoPrecise Genome Engineering Center, School of Life Sciences, Guangzhou University, Guangzhou 510006, China.
Min LiPrecise Genome Engineering Center, School of Life Sciences, Guangzhou University, Guangzhou 510006, China.
Jie LiuGuangzhou Medical University, Guangzhou 511495, China.
Xiaowen XuePrecise Genome Engineering Center, School of Life Sciences, Guangzhou University, Guangzhou 510006, China.
Jingli ZhongPrecise Genome Engineering Center, School of Life Sciences, Guangzhou University, Guangzhou 510006, China.
Jianxiang LinPrecise Genome Engineering Center, School of Life Sciences, Guangzhou University, Guangzhou 510006, China.
Bo YeDepartment of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China.
Jun ChenDepartment of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Yunbo QiaoPrecise Genome Engineering Center, School of Life Sciences, Guangzhou University, Guangzhou 510006, China.
Guangzhou University · CNShanghai Jiao Tong University · CNGuangzhou Medical University · CNQilu Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Base editing tools enable precise genome modifications, disease modeling, and promising gene therapy. However, many human genetic diseases are elicited by multi-nucleotide variants (MNVs) with heterogeneous substitutions at the same genomic locus. Based on the adenine and cytosine base editors, dual base editors that can catalyze concurrent C-to-T and A-to-G editing have been developed, while simultaneous C&G-to-T&A and A&T-to-G&C conversions on the same allele have not been achieved at the desirable site. Here we propose a strategy of combining base editors with dual guide RNAs (gRNAs) that target two overlapped neighboring loci on the opposite strands, which can induce simultaneous C&G-to-T&A and A&T-to-G&C conversions within their overlapping targeting windows. Moreover, one of the paired gRNAs is mutated to perfectly match another gRNA-edited sequence, efficiently facilitating concurrent base conversions on the same allele. To further expand the targeting scopes, PAMless SpRY Cas9-mediated base editors are combined with our optimized dual gRNAs system to induce expected concurrent base editing and to install neighboring pathogenic MNVs in TP53 in cancer cells. In addition, more complex mutation types can be achieved by integrating dual base editors and our dual gRNAs strategy. Thus, we establish a general strategy to efficiently induce MNVs in human genome, helping to dissect the functions of pathogenic MNVs with multifarious types.

Indexed as

C&G-to-T&A and A&T-to-G&C conversionsDual guide RNAs (gRNAs)Multi-nucleotide variant (MNV)SpRYTP53

Identifiers

PMID36698964
PMCPMC9842798
OpenAlexW4313531724

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.